68 / 374
Tratamiento de las enfermedades respiratorias relacionadas con los hongos
68
by improved diagnostic tools. Clin Exp
Allergy. 2012 Jul; 42 (7):1129-38.
9. Duffort O, Palomares O, Lombardero
M, Villalba M, Barber D, Rodríguez Ro-
salía, Polo F. Variability of ole e9 aller-
gen in olive polen extract: Relevance
of minor allergens in immunotherapy
treatments. Int Arch Allergy Immunol
2006; 140:131-138.
10. Prieto L el al. Effect of allergen-specific
immunotherapy with purified alta1 on
AMP responsiveness exhaled nitric
oxide and exhaled breath condensate
ph: a randomized double blindstudy.
Allergy Asthma and Clinical Immuno-
logy 2010,06:27.
11. AI Tabar and cols. Estudio multicéntri-
co, doble ciego, aleatorizado y contro-
lado con placebo, en grupos paralelos,
que evalúa la eficacia y seguridad de
la inmunoterapia con Alt a 1, en pa-
cientes con rinoconjuntivitis alérgica
por
Alternaria
J Invest Allergol and
Clin Immunol 2014, 24, sup 2:90.
81. Experiencia previa del grupo con
Alergia a
Alternaria.
6. Tabar AI, Lizaso MT, García BE, Gómez
B, Echechipía S, Aldunate MT, Ma-
dariaga B, Martínez A. Double-blind,
placebo-controlled study of Alternaria
alternata immunotherapy: clinical effi-
cacy and safety Pediatr Allergy Immu-
nol. 2008 Feb; 19(1):67-75. Experiencia
previa del grupo con Alergia a
Alterna-
ria.
7. Tabar AI, Lizaso MT, García BE, Eche-
chipía S, Olaguibel JM, Rodríguez A.
Tolerance of immunotherapy with a
standardized extract of Alternaria te-
nuis in patients with rhinitis and bron-
chial asthma. J Invest Clinical Immu-
nol 2000; 10(6) 327-333.
8. Barber D, Arias J, Boquete M, Cardona
V, CarrilloT, Gala G, Gamboa P,García-
Robaina JC, Hernández D, Sanz ML,
Tabar AI, Vidal C, Ipsen H, de la Torre
F, Lombardero M. Analysis of mite
allergic patients in a diverse territory